Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis b virus infection, in vitro
Open Access
- 1 June 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (12) , 1815-1822
- https://doi.org/10.1016/s0006-2952(97)82446-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue cultureAntimicrobial Agents and Chemotherapy, 1994
- Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitroAntimicrobial Agents and Chemotherapy, 1994
- Zidovudine inhibits hepatitis B virus replicationAntiviral Research, 1992
- Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replicationAntiviral Research, 1992
- Failure of acyclovir to enhance the antiviral effect of α lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis BJournal of Hepatology, 1992
- Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosidesAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirusAntimicrobial Agents and Chemotherapy, 1989
- Relation of the hepatitis B virus carrier state to hepatocellular carcinomaHepatology, 1987
- Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2′-deoxyuridineAntiviral Research, 1984
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982